EUDA Health Holdings Limited (NASDAQ: EUDAW) Stock Competitors & Peer Comparison
See EUDAW's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for EUDAW and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| EUDAW | $0.02 | +18.93% | 926.3K | 0.03 | $0.80 | N/A |
| VEEV | $195.38 | -1.01% | 31.7B | 23.46 | $8.33 | N/A |
| GEHC | $63.07 | -4.00% | 28.7B | 13.83 | $4.56 | +0.22% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $70.69 | +3.71% | 13.9B | 57.01 | $1.24 | N/A |
| BTSGU | $231.53 | +1.23% | 13.5B | 209.36 | $1.11 | N/A |
| TEM | $52.47 | -2.09% | 9.2B | -104.94 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $97.67 | +2.73% | 8.3B | 23.06 | $4.28 | N/A |
| HNGE | $87.09 | +1.29% | 6.7B | 44.66 | $1.95 | N/A |
Stock Comparison
Veeva Systems Inc. (NYSE: VEEV)
EUDAW vs VEEV Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, VEEV has a market cap of 31.7B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while VEEV trades at $195.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas VEEV's P/E ratio is 23.46. In terms of profitability, EUDAW's ROE is +0.70%, compared to VEEV's ROE of +0.13%. Regarding short-term risk, EUDAW is more volatile compared to VEEV. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check VEEV's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
EUDAW vs GEHC Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, GEHC has a market cap of 28.7B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while GEHC trades at $63.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas GEHC's P/E ratio is 13.83. In terms of profitability, EUDAW's ROE is +0.70%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, EUDAW is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
EUDAW vs GEHCV Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas GEHCV's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, EUDAW is more volatile compared to GEHCV. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
EUDAW vs BTSG Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, BTSG has a market cap of 13.9B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while BTSG trades at $70.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas BTSG's P/E ratio is 57.01. In terms of profitability, EUDAW's ROE is +0.70%, compared to BTSG's ROE of +0.17%. Regarding short-term risk, EUDAW is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
EUDAW vs BTSGU Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, BTSGU has a market cap of 13.5B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while BTSGU trades at $231.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas BTSGU's P/E ratio is 209.36. In terms of profitability, EUDAW's ROE is +0.70%, compared to BTSGU's ROE of +0.17%. Regarding short-term risk, EUDAW is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
EUDAW vs TEM Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, TEM has a market cap of 9.2B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while TEM trades at $52.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas TEM's P/E ratio is -104.94. In terms of profitability, EUDAW's ROE is +0.70%, compared to TEM's ROE of -0.70%. Regarding short-term risk, EUDAW is more volatile compared to TEM. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
EUDAW vs SGFY Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SGFY's P/E ratio is 70.91. In terms of profitability, EUDAW's ROE is +0.70%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, EUDAW is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
EUDAW vs HQY Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, HQY has a market cap of 8.3B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while HQY trades at $97.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas HQY's P/E ratio is 23.06. In terms of profitability, EUDAW's ROE is +0.70%, compared to HQY's ROE of +0.11%. Regarding short-term risk, EUDAW is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
EUDAW vs HNGE Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, HNGE has a market cap of 6.7B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while HNGE trades at $87.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas HNGE's P/E ratio is 44.66. In terms of profitability, EUDAW's ROE is +0.70%, compared to HNGE's ROE of -1.39%. Regarding short-term risk, EUDAW is more volatile compared to HNGE. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
EUDAW vs RCM Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, RCM has a market cap of 6B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas RCM's P/E ratio is -102.21. In terms of profitability, EUDAW's ROE is +0.70%, compared to RCM's ROE of +0.00%. Regarding short-term risk, EUDAW is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check RCM's competition here
10x Genomics, Inc. (NASDAQ: TXG)
EUDAW vs TXG Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, TXG has a market cap of 5.6B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while TXG trades at $43.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas TXG's P/E ratio is -257.29. In terms of profitability, EUDAW's ROE is +0.70%, compared to TXG's ROE of -0.03%. Regarding short-term risk, EUDAW is more volatile compared to TXG. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TXG's competition here
Doximity, Inc. (NYSE: DOCS)
EUDAW vs DOCS Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, DOCS has a market cap of 4B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while DOCS trades at $21.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas DOCS's P/E ratio is 14.07. In terms of profitability, EUDAW's ROE is +0.70%, compared to DOCS's ROE of +0.19%. Regarding short-term risk, EUDAW is more volatile compared to DOCS. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check DOCS's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
EUDAW vs ONEM Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ONEM's P/E ratio is -7.77. In terms of profitability, EUDAW's ROE is +0.70%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, EUDAW is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
EUDAW vs PRVA Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, PRVA has a market cap of 3.4B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while PRVA trades at $26.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas PRVA's P/E ratio is 168.13. In terms of profitability, EUDAW's ROE is +0.70%, compared to PRVA's ROE of +0.03%. Regarding short-term risk, EUDAW is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check PRVA's competition here
Progyny, Inc. (NASDAQ: PGNY)
EUDAW vs PGNY Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, PGNY has a market cap of 2.5B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while PGNY trades at $31.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas PGNY's P/E ratio is 23.31. In terms of profitability, EUDAW's ROE is +0.70%, compared to PGNY's ROE of +0.13%. Regarding short-term risk, EUDAW is more volatile compared to PGNY. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check PGNY's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
EUDAW vs HTFL Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, HTFL has a market cap of 2.2B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while HTFL trades at $24.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas HTFL's P/E ratio is -12.92. In terms of profitability, EUDAW's ROE is +0.70%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, EUDAW is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
EUDAW vs WGS Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, WGS has a market cap of 1.9B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while WGS trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas WGS's P/E ratio is 74.68. In terms of profitability, EUDAW's ROE is +0.70%, compared to WGS's ROE of -0.28%. Regarding short-term risk, EUDAW is more volatile compared to WGS. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check WGS's competition here
Teladoc Health, Inc. (NYSE: TDOC)
EUDAW vs TDOC Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, TDOC has a market cap of 1.7B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while TDOC trades at $9.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas TDOC's P/E ratio is -10.47. In terms of profitability, EUDAW's ROE is +0.70%, compared to TDOC's ROE of -0.12%. Regarding short-term risk, EUDAW is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TDOC's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
EUDAW vs NXGN Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas NXGN's P/E ratio is -266.00. In terms of profitability, EUDAW's ROE is +0.70%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, EUDAW is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
EUDAW vs OMDA Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while OMDA trades at $23.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas OMDA's P/E ratio is 338.57. In terms of profitability, EUDAW's ROE is +0.70%, compared to OMDA's ROE of -0.03%. Regarding short-term risk, EUDAW is more volatile compared to OMDA. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
EUDAW vs AGTI Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas AGTI's P/E ratio is -71.79. In terms of profitability, EUDAW's ROE is +0.70%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, EUDAW is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check AGTI's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
EUDAW vs GDRX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, GDRX has a market cap of 1.1B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while GDRX trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas GDRX's P/E ratio is 9.52. In terms of profitability, EUDAW's ROE is +0.70%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, EUDAW is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check GDRX's competition here
Certara, Inc. (NASDAQ: CERT)
EUDAW vs CERT Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CERT has a market cap of 1.1B. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CERT trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CERT's P/E ratio is 17.77. In terms of profitability, EUDAW's ROE is +0.70%, compared to CERT's ROE of -0.01%. Regarding short-term risk, EUDAW is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
EUDAW vs CCLDO Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CCLDO's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, EUDAW is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
EUDAW vs HSTM Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, HSTM has a market cap of 845.5M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while HSTM trades at $28.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas HSTM's P/E ratio is 38.08. In terms of profitability, EUDAW's ROE is +0.70%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, EUDAW is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check HSTM's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
EUDAW vs WGSWW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, WGSWW has a market cap of 748M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas WGSWW's P/E ratio is -0.02. In terms of profitability, EUDAW's ROE is +0.70%, compared to WGSWW's ROE of -0.28%. Regarding short-term risk, EUDAW is less volatile compared to WGSWW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check WGSWW's competition here
Phreesia, Inc. (NYSE: PHR)
EUDAW vs PHR Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, PHR has a market cap of 662M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while PHR trades at $10.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas PHR's P/E ratio is 38.25. In terms of profitability, EUDAW's ROE is +0.70%, compared to PHR's ROE of +0.03%. Regarding short-term risk, EUDAW is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check PHR's competition here
Evolent Health, Inc. (NYSE: EVH)
EUDAW vs EVH Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, EVH has a market cap of 652.4M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while EVH trades at $5.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas EVH's P/E ratio is 580.00. In terms of profitability, EUDAW's ROE is +0.70%, compared to EVH's ROE of -0.78%. Regarding short-term risk, EUDAW is more volatile compared to EVH. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check EVH's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
EUDAW vs MPLN-WT Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to MPLN-WT's ROE of +2.06%. Regarding short-term risk, EUDAW is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
EUDAW vs ACCD Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ACCD's P/E ratio is -3.08. In terms of profitability, EUDAW's ROE is +0.70%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, EUDAW is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
EUDAW vs SHCR Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SHCR's P/E ratio is -3.76. In terms of profitability, EUDAW's ROE is +0.70%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, EUDAW is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SHCR's competition here
Claritev Corporation (NYSE: CTEV)
EUDAW vs CTEV Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CTEV has a market cap of 517.5M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CTEV trades at $30.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CTEV's P/E ratio is -2.33. In terms of profitability, EUDAW's ROE is +0.70%, compared to CTEV's ROE of +2.06%. Regarding short-term risk, EUDAW is more volatile compared to CTEV. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CTEV's competition here
NRC Health (NASDAQ: NRC)
EUDAW vs NRC Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, NRC has a market cap of 490.8M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while NRC trades at $21.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas NRC's P/E ratio is 26.56. In terms of profitability, EUDAW's ROE is +0.70%, compared to NRC's ROE of +0.57%. Regarding short-term risk, EUDAW is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check NRC's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
EUDAW vs SOPH Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SOPH has a market cap of 403.5M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SOPH trades at $5.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SOPH's P/E ratio is -11.29. In terms of profitability, EUDAW's ROE is +0.70%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, EUDAW is more volatile compared to SOPH. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SOPH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
EUDAW vs SLGCW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, EUDAW's ROE is +0.70%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, EUDAW is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
EUDAW vs SLGC Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SLGC's P/E ratio is -3.04. In terms of profitability, EUDAW's ROE is +0.70%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, EUDAW is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
EUDAW vs TBRG Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas TBRG's P/E ratio is 9.37. In terms of profitability, EUDAW's ROE is +0.70%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, EUDAW is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
EUDAW vs MPLN Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas MPLN's P/E ratio is -0.23. In terms of profitability, EUDAW's ROE is +0.70%, compared to MPLN's ROE of +2.06%. Regarding short-term risk, EUDAW is more volatile compared to MPLN. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check MPLN's competition here
Simulations Plus, Inc. (NASDAQ: SLP)
EUDAW vs SLP Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SLP has a market cap of 368.7M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SLP trades at $18.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SLP's P/E ratio is 20.72. In terms of profitability, EUDAW's ROE is +0.70%, compared to SLP's ROE of +0.06%. Regarding short-term risk, EUDAW is more volatile compared to SLP. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SLP's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
EUDAW vs TRHC Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas TRHC's P/E ratio is -4.27. In terms of profitability, EUDAW's ROE is +0.70%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, EUDAW is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
EUDAW vs SMFR Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SMFR's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to SMFR's ROE of -0.28%. Regarding short-term risk, EUDAW is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
EUDAW vs SPOK Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SPOK has a market cap of 222.2M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SPOK trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SPOK's P/E ratio is 17.73. In terms of profitability, EUDAW's ROE is +0.70%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, EUDAW is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SPOK's competition here
So-Young International Inc. (NASDAQ: SY)
EUDAW vs SY Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SY has a market cap of 220.4M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SY trades at $1.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SY's P/E ratio is -5.09. In terms of profitability, EUDAW's ROE is +0.70%, compared to SY's ROE of -0.16%. Regarding short-term risk, EUDAW is more volatile compared to SY. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SY's competition here
American Well Corporation (NYSE: AMWL)
EUDAW vs AMWL Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, AMWL has a market cap of 220.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while AMWL trades at $13.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas AMWL's P/E ratio is -2.54. In terms of profitability, EUDAW's ROE is +0.70%, compared to AMWL's ROE of -0.35%. Regarding short-term risk, EUDAW is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check AMWL's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
EUDAW vs HCAT Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, HCAT has a market cap of 166.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while HCAT trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas HCAT's P/E ratio is 11.25. In terms of profitability, EUDAW's ROE is +0.70%, compared to HCAT's ROE of -1.00%. Regarding short-term risk, EUDAW is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check HCAT's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
EUDAW vs CPSI Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CPSI's P/E ratio is -183.80. In terms of profitability, EUDAW's ROE is +0.70%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, EUDAW is more volatile compared to CPSI. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
EUDAW vs OPRX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, OPRX has a market cap of 125.5M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while OPRX trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas OPRX's P/E ratio is 6.14. In terms of profitability, EUDAW's ROE is +0.70%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, EUDAW is more volatile compared to OPRX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check OPRX's competition here
Augmedix, Inc. (NASDAQ: AUGX)
EUDAW vs AUGX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas AUGX's P/E ratio is -4.99. In terms of profitability, EUDAW's ROE is +0.70%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, EUDAW is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
EUDAW vs CCLD Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CCLD has a market cap of 98.6M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CCLD trades at $2.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CCLD's P/E ratio is 8.59. In terms of profitability, EUDAW's ROE is +0.70%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, EUDAW is more volatile compared to CCLD. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
EUDAW vs DH Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, DH has a market cap of 80.1M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while DH trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas DH's P/E ratio is 2.92. In terms of profitability, EUDAW's ROE is +0.70%, compared to DH's ROE of -0.67%. Regarding short-term risk, EUDAW is more volatile compared to DH. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
EUDAW vs FORA Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas FORA's P/E ratio is -24.11. In terms of profitability, EUDAW's ROE is +0.70%, compared to FORA's ROE of -0.17%. Regarding short-term risk, EUDAW is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
EUDAW vs CCLDP Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CCLDP's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, EUDAW is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMD)
EUDAW vs ONMD Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ONMD has a market cap of 38.7M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ONMD trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ONMD's P/E ratio is -4.53. In terms of profitability, EUDAW's ROE is +0.70%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, EUDAW is more volatile compared to ONMD. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
EUDAW vs SNCE Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SNCE's P/E ratio is -0.27. In terms of profitability, EUDAW's ROE is +0.70%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, EUDAW is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
EUDAW vs AKLI Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas AKLI's P/E ratio is -0.71. In terms of profitability, EUDAW's ROE is +0.70%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, EUDAW is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
EUDAW vs SHLT Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SHLT's P/E ratio is -3.87. In terms of profitability, EUDAW's ROE is +0.70%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, EUDAW is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
EUDAW vs SHCRW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, EUDAW's ROE is +0.70%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, EUDAW is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
EUDAW vs ONMDW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ONMDW has a market cap of 27.7M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ONMDW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, EUDAW is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
EUDAW vs STRM Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas STRM's P/E ratio is -2.40. In terms of profitability, EUDAW's ROE is +0.70%, compared to STRM's ROE of -0.32%. Regarding short-term risk, EUDAW is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
EUDAW vs RNLX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas RNLX's P/E ratio is -0.33. In terms of profitability, EUDAW's ROE is +0.70%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, EUDAW is more volatile compared to RNLX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
EUDAW vs LIFW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas LIFW's P/E ratio is -0.02. In terms of profitability, EUDAW's ROE is +0.70%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, EUDAW is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check LIFW's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
EUDAW vs EUDA Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, EUDA has a market cap of 21.1M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while EUDA trades at $11.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas EUDA's P/E ratio is -21.32. In terms of profitability, EUDAW's ROE is +0.70%, compared to EUDA's ROE of +0.70%. Regarding short-term risk, EUDAW is more volatile compared to EUDA. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check EUDA's competition here
Babylon Holdings Limited (NYSE: BBLN)
EUDAW vs BBLN Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas BBLN's P/E ratio is -0.04. In terms of profitability, EUDAW's ROE is +0.70%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, EUDAW is more volatile compared to BBLN. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
EUDAW vs BEATW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, BEATW has a market cap of 13.4M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while BEATW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas BEATW's P/E ratio is -0.04. In terms of profitability, EUDAW's ROE is +0.70%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, EUDAW is less volatile compared to BEATW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
EUDAW vs ETAO Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ETAO's P/E ratio is -0.01. In terms of profitability, EUDAW's ROE is +0.70%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, EUDAW is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check ETAO's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
EUDAW vs BFRG Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, BFRG has a market cap of 7.5M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while BFRG trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas BFRG's P/E ratio is -1.20. In terms of profitability, EUDAW's ROE is +0.70%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, EUDAW is more volatile compared to BFRG. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check BFRG's competition here
Cue Health Inc. (NASDAQ: HLTH)
EUDAW vs HLTH Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, HLTH has a market cap of 6.9M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while HLTH trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas HLTH's P/E ratio is -0.02. In terms of profitability, EUDAW's ROE is +0.70%, compared to HLTH's ROE of -0.90%. Regarding short-term risk, EUDAW is less volatile compared to HLTH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check HLTH's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
EUDAW vs SCNX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SCNX has a market cap of 6.4M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SCNX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SCNX's P/E ratio is -0.16. In terms of profitability, EUDAW's ROE is +0.70%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, EUDAW is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
EUDAW vs UPH-WT Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, EUDAW is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
EUDAW vs UPH Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas UPH's P/E ratio is -0.07. In terms of profitability, EUDAW's ROE is +0.70%, compared to UPH's ROE of -1.05%. Regarding short-term risk, EUDAW is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check UPH's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
EUDAW vs MGRX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, MGRX has a market cap of 4.2M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while MGRX trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas MGRX's P/E ratio is -0.31. In terms of profitability, EUDAW's ROE is +0.70%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, EUDAW is more volatile compared to MGRX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check MGRX's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
EUDAW vs PEAR Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas PEAR's P/E ratio is -0.08. In terms of profitability, EUDAW's ROE is +0.70%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, EUDAW is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
EUDAW vs PEARW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas PEARW's P/E ratio is -0.00. In terms of profitability, EUDAW's ROE is +0.70%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, EUDAW is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
EUDAW vs OTRK Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas OTRK's P/E ratio is -0.02. In terms of profitability, EUDAW's ROE is +0.70%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, EUDAW is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check OTRK's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
EUDAW vs VSEEW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, VSEEW has a market cap of 2.2M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while VSEEW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas VSEEW's P/E ratio is -0.06. In terms of profitability, EUDAW's ROE is +0.70%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, EUDAW is more volatile compared to VSEEW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check VSEEW's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
EUDAW vs HCTI Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, HCTI has a market cap of 2.1M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while HCTI trades at $1.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas HCTI's P/E ratio is -0.23. In terms of profitability, EUDAW's ROE is +0.70%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, EUDAW is more volatile compared to HCTI. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check HCTI's competition here
CareMax, Inc. (NASDAQ: CMAX)
EUDAW vs CMAX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CMAX's P/E ratio is -0.00. In terms of profitability, EUDAW's ROE is +0.70%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, EUDAW is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CMAX's competition here
VSee Health, Inc. (NASDAQ: VSEE)
EUDAW vs VSEE Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, VSEE has a market cap of 1.6M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while VSEE trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas VSEE's P/E ratio is -0.19. In terms of profitability, EUDAW's ROE is +0.70%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, EUDAW is more volatile compared to VSEE. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check VSEE's competition here
Aclarion, Inc. (NASDAQ: ACON)
EUDAW vs ACON Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ACON trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ACON's P/E ratio is -0.24. In terms of profitability, EUDAW's ROE is +0.70%, compared to ACON's ROE of -0.54%. Regarding short-term risk, EUDAW is more volatile compared to ACON. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
EUDAW vs LIFWZ Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, EUDAW is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check LIFWZ's competition here
SCWorx Corp. (NASDAQ: WORX)
EUDAW vs WORX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, WORX has a market cap of 693.4K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while WORX trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas WORX's P/E ratio is -0.76. In terms of profitability, EUDAW's ROE is +0.70%, compared to WORX's ROE of -0.65%. Regarding short-term risk, EUDAW is more volatile compared to WORX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check WORX's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
EUDAW vs MSPRZ Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, EUDAW is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERNW)
EUDAW vs KERNW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas KERNW's P/E ratio is -0.00. In terms of profitability, EUDAW's ROE is +0.70%, compared to KERNW's ROE of -0.17%. Regarding short-term risk, EUDAW is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
EUDAW vs KERN Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas KERN's P/E ratio is -0.01. In terms of profitability, EUDAW's ROE is +0.70%, compared to KERN's ROE of -0.17%. Regarding short-term risk, EUDAW is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
EUDAW vs LIFWW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas LIFWW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, EUDAW is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
EUDAW vs ZCMD Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ZCMD has a market cap of 58K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ZCMD trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ZCMD's P/E ratio is -0.06. In terms of profitability, EUDAW's ROE is +0.70%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, EUDAW is more volatile compared to ZCMD. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
EUDAW vs CMAXW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CMAXW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, EUDAW is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
EUDAW vs ACONW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, ACONW has a market cap of 11.7K. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas ACONW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to ACONW's ROE of -0.54%. Regarding short-term risk, EUDAW is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check ACONW's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
EUDAW vs AFFX Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, AFFX has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas AFFX's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, EUDAW is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check AFFX's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
EUDAW vs SMFRW Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas SMFRW's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to SMFRW's ROE of -0.28%. Regarding short-term risk, EUDAW is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check SMFRW's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
EUDAW vs CHNGU Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CHNGU's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, EUDAW is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CHNGU's competition here
NantHealth, Inc. (NASDAQ: NH)
EUDAW vs NH Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, NH has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas NH's P/E ratio is -0.12. In terms of profitability, EUDAW's ROE is +0.70%, compared to NH's ROE of +0.35%. Regarding short-term risk, EUDAW is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check NH's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
EUDAW vs MSPRV Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas MSPRV's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to MSPRV's ROE of N/A. Regarding short-term risk, EUDAW is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for EUDAW.Check MSPRV's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
EUDAW vs CNVY Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CNVY has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CNVY's P/E ratio is -71.50. In terms of profitability, EUDAW's ROE is +0.70%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, EUDAW is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
EUDAW vs MTBCP Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas MTBCP's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, EUDAW is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check MTBCP's competition here
CareCloud, Inc. (NASDAQ: MTBC)
EUDAW vs MTBC Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, MTBC has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas MTBC's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to MTBC's ROE of +0.17%. Regarding short-term risk, EUDAW is more volatile compared to MTBC. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check MTBC's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
EUDAW vs IMS Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, IMS has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas IMS's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to IMS's ROE of +0.27%. Regarding short-term risk, EUDAW is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check IMS's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
EUDAW vs KURIU Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, KURIU has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas KURIU's P/E ratio is N/A. In terms of profitability, EUDAW's ROE is +0.70%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, EUDAW is more volatile compared to KURIU. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check KURIU's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
EUDAW vs CHNG Comparison July 2026
EUDA Health Holdings Limited (NASDAQ: EUDAW) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, EUDAW stands at 926.3K. In comparison, CHNG has a market cap of 0. Regarding current trading prices, EUDAW is priced at $0.02 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
EUDAW currently has a P/E ratio of 0.03, whereas CHNG's P/E ratio is -152.72. In terms of profitability, EUDAW's ROE is +0.70%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, EUDAW is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for EUDAW.Check CHNG's competition here